Maxar's rocketing closer to J.P. Morgan's target price -- but it's not there yet.
Investors are jumping in ahead of a data presentation tomorrow.
The oil reservoir specialist is riding crude oil’s wave today.
A generous buyout offer has given investors something to cheer about.
J.P. Morgan rides to Enphase's rescue after Citron's short attack.
Not every oil stock is riding high on the oil price increase.
The midstream company received an offer it couldn’t refuse.
Shares sink after the company announces a management shakeup and cuts its full-year guidance. Here's what investors need to know.
A spike in oil prices adds fresh turbulence to an already cloudy outlook for the airline.
The utility has reached an important milestone in its effort to reorganize.
The cloud and cybersecurity company jumps on its first day of trading.
Investor buyout hopes take a hit after the company's founder backs away.
An insider took advantage of the slumping stock price to great effect.
Investors appear to be taking profits off the table after the biotech announced a key FDA approval.
After three days of monster gains, shares of the ailing retailer finally faded.
Short report from Citron Research torpedoes SolarEdge and Enphase shares.
A new CEO looks like bad news to some investors and analysts.
Investors continue to grapple with the uncertainty hanging over the company.
The company's long R&D Day presentation gave investors reasons for optimism.
Shares sink after the company reports disappointing quarterly results and provides downbeat guidance. Here are the must-know details for investors.